top of page

Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg

Product details

Registration number: SIN14329P

Classification: Prescription Only

Active ingredients:

  • Imipenem Monohydrate 530mg corresponding to Imipenem
  • Sodium Cilastatin 530mg Corresponding to Cilastatin

Strength:

  • 500mg
  • 500mg

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: NOVEM PHARMA PRIVATE LIMITED

ATC code: J01D H51

HSA approval date: 20 March 2013

Manufacturer(s):

  • ACS DOBFAR S.p.A (Filling of Drug product sterile bulk)
  • ACS Dobfar SpA 2: Addetta Site (Drug product bulk)

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14329P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Imipenem Monohydrate 530mg corresponding to Imipenem
  • Sodium Cilastatin 530mg Corresponding to Cilastatin

Strength:

  • 500mg
  • 500mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVEM PHARMA PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • ACS DOBFAR S.p.A (Filling of Drug product sterile bulk)
  • ACS Dobfar SpA 2: Addetta Site (Drug product bulk)

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14329P or the exact product name Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Imipenem + Cilastatin Mevon Powder for solution for Injection 500 mg + 500 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14329P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page